Rezulin (REZ-u-lin, troglitazone), for Type II diabetes
January 1997
The FDA will soon approve Rezulin (REZ-u-lin, troglitazone), for Type II diabetes.
It has the potential to be a significant advance.
Troglitazone helps reduce insulin resistance...an underlying metabolic defect in most patients with Type II diabetes.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote